Prostate Cancer - Results from #19780

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer - Abstract September 3, 2014

Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy - Abstract September 3, 2014

The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting - Abstract September 3, 2014

Integrative genomic analysis for the discovery of biomarkers in prostate cancer - Abstract September 3, 2014

Castration-resistant prostate cancer: Latest evidence and therapeutic implications - Abstract September 2, 2014

The results of treatment of prostate cancer bone metastases after CyberKnife radiosurgery - Abstract September 2, 2014

Severe hypocalcemia due to Denosumab in metastatic prostate cancer - Abstract September 2, 2014

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone - Abstract September 2, 2014

Managed care and the dissemination of robotic prostatectomy - Abstract September 2, 2014

Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy - Abstract September 2, 2014

Prostate cancer: Review in 2014 - Abstract September 2, 2014

Rectal bleeding after radiotherapy for prostate cancer - Abstract September 2, 2014

Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients - Abstract September 2, 2014

Large gastrointestinal stromal tumor and advanced adenocarcinoma in the rectum coexistent with an incidental prostate carcinoma: A case report - Abstract September 2, 2014

Upper limit of cancer extent on biopsy defining very low risk prostate cancer - Abstract September 2, 2014

Usefulness of ultra-sensitive prostate-specific antigen following radical prostatectomy - Abstract September 2, 2014

Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone - Abstract September 2, 2014

Ipilimumab: A potential immunologic agent in the treatment of metastatic castration-resistant prostate cancer - Abstract August 29, 2014

Personalizing prostate cancer therapy: The way forward - Abstract August 29, 2014

Argument for prostate cancer screening in populations of African-Caribbean origin - Abstract August 29, 2014

Page 990 of 1436